About Apidra Solostar Ready Pen Sanofi
Apidra Solostar Ready Pen is a rapid-acting insulin analogue developed by Sanofi for comprehensive metabolic research applications. This pre-filled pen delivery system contains insulin glulisine, a human insulin analogue engineered through recombinant DNA technology in Escherichia coli. The compound exhibits rapid onset kinetics and short duration of action, making it valuable for investigating postprandial glucose dynamics and insulin response mechanisms in laboratory settings. Researchers studying diabetes pathophysiology, glucose homeostasis, and pancreatic beta-cell function frequently investigate this formulation due to its predictable pharmacokinetic profile. The ready-pen format ensures precise dosing capabilities essential for controlled research protocols examining insulin signaling pathways and glucose metabolism.
Scientific Applications
Laboratory investigations utilising Apidra focus on rapid glucose lowering mechanisms and insulin receptor binding studies. The compound demonstrates faster absorption compared to regular human insulin, with peak activity occurring within 30-90 minutes in preclinical models. Research teams at Stroid UK Shop examine its interaction with glucose transporters and downstream metabolic cascades. Studies investigating insulin resistance mechanisms frequently compare this rapid-acting analogue with other formulations available through our insulin research category. The stable formulation allows researchers to study dose-response relationships and temporal glucose dynamics. Scientists also investigate its potential interactions with compounds from our selective androgen receptor modulator range and peptide research collection when examining metabolic pathway intersections.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Insulin glulisine |
| Manufacturer | Sanofi |
| Delivery System | Pre-filled pen injector |
| Formulation | Ready-to-use solution |
| Storage Temperature | 2-8°C (unopened), room temp (in-use) |
| Research Grade | Pharmaceutical standard |
| SKU | EU12751 |
Research Compliance
This insulin glulisine research product is supplied exclusively for in-vitro laboratory research and educational purposes. Not approved for human therapeutic use or veterinary applications. Research institutions must ensure appropriate storage conditions and handling protocols are maintained. All investigations should be conducted under proper laboratory supervision with appropriate safety measures. Researchers must comply with institutional review board requirements and local regulations governing insulin research studies. This product is not intended for diagnostic, therapeutic, or clinical applications.
